LIVE |
MD&A for the period ended January 31, 2024 |
MD&A (Management Discussion and Analysis) |
28/03/2024 |
Open Filing (1.74 MB) |
LIVE |
Interim Financial Statements for the 3 months ended January 31, 2024 |
Interim Financial Statements |
28/03/2024 |
Open Filing (204.11 KB) |
OMGA |
Financial Statements Request Form |
Other |
28/03/2024 |
Open Filing (89.48 KB) |
OMGA |
Form of Proxy |
Form of Proxy |
28/03/2024 |
Open Filing (129.08 KB) |
OMGA |
Management Information Circular |
Management Proxy/Information Circular |
28/03/2024 |
Open Filing (521.83 KB) |
OMGA |
Notice and Access Notification to Shareholders and Notice of the Meeting |
Notice of Meeting |
28/03/2024 |
Open Filing (236.68 KB) |
FFNT |
Notice of Proposed Stock Option Grant or Amendment (March 27, 2024) |
Proposed Stock Option |
28/03/2024 |
Open Filing (178.62 KB) |
PATH |
Quarterly Listing Statement |
Quarterly Listing Statement |
28/03/2024 |
Open Filing (5.89 MB) |
WERX |
Form 5 - Quarterly Listing Statement |
Quarterly Listing Statement |
28/03/2024 |
Open Filing (762.11 KB) |
WERX |
Form 52-109FV2 Certification of Interim Filings (CFO) |
Other |
28/03/2024 |
Open Filing (175.26 KB) |